Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery

Exclusion Criteria

• •Patients who have had chemotherapy or radiotherapy within 4 weeks (6 weeks for nitrosoureas or mitomycin C) prior to entering the study or those who have not recovered from adverse events due to agents administered more than 4 weeks earlier
• •Patients with known brain metastases should be excluded from this clinical trial
• •Patients with porphyria, or with known hypersensitivity to porphyrins or porphyrin-like compounds
• •White blood cell (WBC) \< 4,000
• •Platelet count \< 100,000
• •Total serum bilirubin \> 2 mg/dL
• •Serum creatinine \> 2 mg/dL
• •Alkaline phosphatase (hepatic) or serum glutamic oxaloacetic transaminase (SGOT) \> 3 times the upper normal limit
• •Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
• •Pregnant or nursing female subjects
• •Unwilling or unable to follow protocol requirements
• •Any condition which in the Investigator's opinion deems the subject an unsuitable candidate to receive study drug
• •Received an investigational agent within 30 days prior to enrollment